Oncopharmpod
Belzutifan and Recent Updates
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:16:30
- Mas informaciones
Informações:
Sinopsis
Belzutifan, the 1st hypoxia-inducible factor (HIF) inhibitor is FDA-approved. Plus, expanded indication approvals for nivolumab, dostarlimab, lenvatinib/pembrolizumab, & Ivosidenib. Finally, my Top 5 Rolling Stones Songs (14:30).
